Patritumab (P) or placebo (PBO) plus cetuximab (C) and platinum-based therapy in squamous cell carcinoma of the head and neck (SCCHN): a phase 2 study.

Kevin J. Harrington,Martin Forster,Magnus T. Dillon,Lorna Grove,Sola Adeleke,Shuquan Chen,Jane S. Diamond,Henrik Hannus,Kandance Cooper,Jonathan Greenberg

Patritumab (P) or placebo (PBO) plus cetuximab (C) and platinum-based therapy in squamous cell carcinoma of the head and neck (SCCHN): a phase 2 study.

2016

Kevin J. Harrington
Martin Forster
Magnus T. Dillon
Lorna Grove
Sola Adeleke
Shuquan Chen
Jane S. Diamond
Henrik Hannus
Kandance Cooper
Jonathan Greenberg

TPS6104Background: P is a fully human monoclonal antibody against human epidermal growth factor receptor 3. P blocks activation by the ligand, heregulin (HRG), inducing receptor internalization. Ev...

Keywords:

Carcinoma
Cetuximab
Placebo
Physical therapy
Cancer research
Patritumab
Platinum
Medicine
Phases of clinical research
Neuregulin
head and neck
basal cell
Monoclonal antibody
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations